Medical care

Memoray has recently completed a Series B financing of tens of millions of RMB.
This round of financing was jointly invested by Zeyu Capital, Suzhou Proxima Ventures, and Tibet Ruishang Venture Capital. This is a new round of financing after the company received tens of millions of yuan in Series A financing in May this year.

On November 17, JD Health and AstraZeneca, the world’s leading multinational pharmaceutical company, reached a strategic cooperation.

Beijing Changmugu Medical Technology, or Changmugu, an orthopedic artificial intelligence high-tech company, recently announced the completion of its Series A+ round of financing worth tens of millions of yuan, which was exclusively invested by Lenovo Ventures.

Lu Daopei Medical, a blood disease specialist medical group, has completed its Series B round of financing raising more than 100 million yuan.

On September 2nd, phat.jd.com, the health section of JD.com, launched a new service platform of Chinese medicine on which users can inquire about Chinese medicine online and buy the medicine according to the prescription.

Recently, Beijing Tsingying Huakang Technology Co., Ltd. or Tsimaging Technology completed its Pre-A round of equity financing worth tens of millions of yuan, led by BOHE Angel Fund and jointly invested by TusStar Ventures.

Forerunner Medical, a medical device technology company, recently announced that it had raised hundreds of millions of yuan in its Series B round of financing; which was led by CICC Capital, and followed by Cenova Capital, Apricot Capital, Dalton Investment and China Renaissance Capital.

On September 1, China Isotope & Radiation Corporation (CIRC) signed an exclusive distribution agreement with Bayer.

The world’s first inactivated COVID-19 vaccine developed and produced by Sinopharm Group’s China National Biotec Group (CNBG) was approved by the National Food, Drugs and Medical Technology Administration (ANMAT) under the Ministry of Health of Argentina on August 13 for trial test.

China has officially launched the emergency use of the Covid-19 vaccine on July 22, Zheng Zhongwei, an official of the National Health Commission, said on CCTV’s Dialogue program.